Role of Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ Cell Tumors

被引：8

作者：

Nguyen, Carvell T. ^{[1
]}

Stephenson, Andrew J. ^{[1
]}

机构：

[1] Cleveland Clin, Glickman Urol & Kidney Inst, Ctr Urol Oncol, Cleveland, OH 44195 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2011年 / 25卷 / 03期

关键词：

Testicular neoplasms; Neoplasms; Germ cell; Embryonal; Chemotherapy; Retroperitoneum; Lymph node excision; Neoplasm staging; NONSEMINOMATOUS TESTICULAR CANCER; EUROPEAN CONSENSUS CONFERENCE; POSITRON-EMISSION-TOMOGRAPHY; RESIDUAL MASSES; OUTCOME ANALYSIS; MALIGNANT-TRANSFORMATION; COMBINATION CHEMOTHERAPY; SURGICAL RESECTION; THORACIC MASSES; SALVAGE SURGERY;

D O I：

10.1016/j.hoc.2011.03.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Advanced germ cell tumors (GCTs) are curable with the appropriate integration of cisplatin-based chemotherapy and postchemotherapy surgical resection of residual masses. For men with retroperitoneal metastases, postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) is a vital component of this treatment algorithm. The rationale for PC-RPLND is based on the consistent 10% to 20% and 35% to 55% incidence of viable malignancy and teratoma, respectively. Prognostic factors and nomograms cannot predict the presence of necrosis with sufficient accuracy to obviate the need for PC-RPLND. This article reviews the indications, technique, and outcomes of PC-RPLND in the management of advanced GCT.

引用

页码：593 / +

页数：13

共 50 条

[41] Retroperitoneal lymph node dissection in the setting of elevated markers
Lakes, Jale
Lusch, Achim
Nini, Alessandro
Albers, Peter
CURRENT OPINION IN UROLOGY, 2018, 28 (05) : 435 - 439
[42] HYPERAMYLASEMIA AFTER POSTCHEMOTHERAPY RETROPERITONEAL LYMPH-NODE DISSECTION FOR TESTIS CANCER
BANIEL, J
LEIBOVITCH, I
FOSTER, RS
ROWLAND, RG
BIHRLE, R
DONOHUE, JP
JOURNAL OF UROLOGY, 1995, 154 (04): : 1373 - 1375
[43] PATIENT SELECTION FOR RETROPERITONEAL LYMPH-NODE DISSECTION AFTER CHEMOTHERAPY FOR NONSEMINOMATOUS GERM-CELL TUMORS
HERR, HW
TONER, GC
GELLER, NL
BOSL, GJ
EUROPEAN UROLOGY, 1991, 19 (01) : 1 - 5
[44] Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: long-term oncologic outcomes
Finelli, Antonio
CURRENT OPINION IN UROLOGY, 2008, 18 (02) : 180 - 184
[45] Weighing Risks and Benefits of Postchemotherapy Retroperitoneal Lymph Node Dissection: Not So Easy
Bosl, George J.
Motzer, Robert J.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 519 - 521
[46] Post-chemotherapy nerve-sparing retroperitoneal lymph node dissection for advanced germ cell tumor
Miki, Tsuneharu
Mizutani, Yoichi
Nakamura, Terukazu
Kawauchi, Akihiro
Nagahara, Akira
Nonomura, Norio
Okuyama, Akihiko
INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (04) : 379 - 382
[47] Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum
Matulewicz, Richard S.
Benfante, Nicole
Funt, Samuel A.
Feldman, Darren R.
Carver, Brett
Doudt, Alexander
Knezevic, Andrea
Sheinfeld, Joel
JOURNAL OF UROLOGY, 2024, 211 (01): : 80 - 89
[48] Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes
Woldu, Solomon L.
Moore, Joseph A.
Ci, Bo
Freifeld, Yuval
Clinton, Timothy N.
Aydin, Ahmet M.
Singla, Nirmish
Krabbe, Laura-Maria
Hutchinson, Ryan C.
Amatruda, James F.
Sagalowsky, Arthur
Lotan, Yair
Arriaga, Yull
Margulis, Vitaly
Xie, Yang
Bagrodia, Aditya
EUROPEAN UROLOGY ONCOLOGY, 2018, 1 (03): : 242 - 251
[49] Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levels
Speir, Ryan W.
Calaway, Adam C.
Einhorn, Lawrence H.
Foster, Richard S.
Cary, Clint
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (08) : 687.e19 - 687.e23
[50] Midline Extraperitoneal Approach for Retroperitoneal Lymph Node Dissection for Testicular Germ Cell Tumor
Kim, Philip
Syan-Bhanvadia, Sumeet
Djaladat, Hooman
Faber, Ken
Tadros, Nicholas N.
Nichols, Craig
Daneshmand, Siamak
UROLOGY, 2012, 80 (04) : 941 - 945

← 1 2 3 4 5 →